Methylation of NRIP3 Is a Synthetic Lethal Marker for Combined PI3K and ATR/ATM Inhibitors in Colorectal Cancer
Lists
Only you see this
Abstract
NRIP3 was frequently methylated in both colorectal adenomatous polyps and CRC. The methylation of NRIP3 may potentially serve as an early detection, late-onset, and poor prognostic marker in CRC. NRIP3 is a potential tumor suppressor. NRIP3 methylation is a potential synthetic lethal marker for combined PI3K and ATR/ATM inhibitors.
BibTeX
@inproceedings{zhang2024methylation,
author = {Meiying Zhang and Xiaoyun Li and James G. Herman and Aiai Gao and Qian Wang and Yuanxin Yao and Fangfang Shen and Kunlun He and Mingzhou Guo},
title = {{Methylation of NRIP3 Is a Synthetic Lethal Marker for Combined PI3K and ATR/ATM Inhibitors in Colorectal Cancer}},
booktitle = {Clinical},
year = {2024},
doi = {10.14309/ctg.0000000000000682},
}Loading related content...